==References==
''https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3841998/''
1. Mikaili P, Sharifi M, SHayegh J, Sarahroodi SH. Etymological review on chemical and pharmaceutical substances of the oriental origin. Int J Anim Vet Adv. 2012;4:40–4. [Google Scholar]
2. Frison G, Favretto D, Zancanaro F, Fazzin G, Ferrara SD. A case of beta-carboline alkaloid intoxication following ingestion of Peganum harmala seed extract. Forensic Sci Int. 2008;179:e37–43. [PubMed] [Google Scholar]
3. El Gendy MA, El-Kadi AO. Peganum harmala L. Differentially modulates cytochrome P450 gene expression in human hepatoma HepG2 cells. Drug Metab Lett. 2009;3:212–6. [PubMed] [Google Scholar]
4. Wanntorp L, Louis P. Swedish museum of natural history. In: Wanntorp L, editor. Flowers on the Tree of Life. Series: Systematics Association Special Volume Series. 1 edition. Cambridge University Press; 2011. Nov 14, p. 326. 2011. [Google Scholar]
5. Sheahan CM, Chase WM. Phylogenetic relationships within zygophyllaceae based on DNA sequences of three plastid regions, with special emphasis on zygophylloideae. Syst Bot. 2000;25:371–84. [Google Scholar]
6. Mahmoudian M, Jalilpour H, Salehian P. Toxicity of Peganum harmala: Review and a case report. Iran J Pharmacol Ther. 2002;1:1–4. [Google Scholar]
7. Herraiz T, González D, Ancín-Azpilicueta C, Arán VJ, Guillén H. beta-Carboline alkaloids in Peganum harmala and inhibition of human monoamine oxidase (MAO) Food Chem Toxicol. 2010;48:839–45. [PubMed] [Google Scholar]
8. Shapira Z, Terkel J, Egozi Y, Nyska A, Friedman J. Abortifacient potential for the epigeal parts of Peganum harmala. J Ethnopharmacol. 1989;27:319–25. [PubMed] [Google Scholar]
9. Tahraoui A, El-Hilaly J, Israili ZH, Lyoussi B. Ethnopharmacological survey of plants used in the traditional treatment of hypertension and diabetes in south-eastern Morocco (Errachidia province) J Ethnopharmacol. 2007;110:105–17. [PubMed] [Google Scholar]
10. Aarons DH, Rossi GV, Orzechowski RF. Cardiovascular actions of three harmala alkaloids: Harmine, harmaline, and harmalol. J Pharm Sci. 1977;66:1244–8. [PubMed] [Google Scholar]
11. Shi CC, Liao JF, Chen CF. Comparative study on the vasorelaxant effects of three harmala alkaloids in vitro. Jpn J Pharmacol. 2001;85:299–305. [PubMed] [Google Scholar]
12. Berrougui H, Martín-Cordero C, Khalil A, Hmamouchi M, Ettaib A, Marhuenda E, et al. Vasorelaxant effects of harmine and harmaline extracted from Peganum harmala L. seeds in isolated rat aorta. Pharmacol Res. 2006;54:150–7. [PubMed] [Google Scholar]
13. Hamsa TP, Kuttan G. Harmine inhibits tumour specific neo-vessel formation by regulating VEGF, MMP, TIMP and pro-inflammatory mediators both in vivo and in vitro. Eur J Pharmacol. 2010;649:64–73. [PubMed] [Google Scholar]
14. Aqel M, Hadidi M. Direct relaxant effect of Peganum harmala seed extract on smooth muscles of rabbit and guinea pig. Pharm Biol. 1991;29:176–82. [Google Scholar]
15. Shi CC, Chen SY, Wang GJ, Liao JF, Chen CF. Vasorelaxant effect of harman. Eur J Pharmacol. 2000;390:319–25. [PubMed] [Google Scholar]
16. Astulla A, Zaima K, Matsuno Y, Hirasawa Y, Ekasari W, Widyawaruyanti A, et al. Alkaloids from the seeds of Peganum harmala showing antiplasmodial and vasorelaxant activities. J Nat Med. 2008;62:470–2. [PubMed] [Google Scholar]
17. Suleiman MS, Reeves JP. Inhibition of Na+-Ca2+ exchange mechanism in cardiac sarcolemmal vesicles by harmaline. Comp Biochem Physiol C. 1987;88:197–200. [PubMed] [Google Scholar]
18. Saeed SA, Farnaz S, Simjee RU, Malik A. Triterpenes and B-sitosterol from piper betle: Isolation, antiplatelet and anti-inflammatory effects. Biochem Soc Trans. 1993;21:462S. [PubMed] [Google Scholar]
19. Leporatti ML, Ghedira K. Comparative analysis of medicinal plants used in traditional medicine in Italy and Tunisia. J Ethnobiol Ethnomed. 2009;5:31. [PMC free article] [PubMed] [Google Scholar]
20. Abu-Irmaileh BE, Afifi FU. Herbal medicine in Jordan with special emphasis on commonly used herbs. J Ethnopharmacol. 2003;89:193–7. [PubMed] [Google Scholar]
21. Farouk L, Laroubi A, Aboufatima R, Benharref A, Chait A. Evaluation of the analgesic effect of alkaloid extract of Peganum harmala L.: Possible mechanisms involved. J Ethnopharmacol. 2008;115:449–54. [PubMed] [Google Scholar]
22. Airaksinen MM, Kari I. beta-Carbolines, psychoactive compounds in the mammalian body. Part II: Effects. Med Biol. 1981;59:190–211. [PubMed] [Google Scholar]
23. Monsef HR, Ghobadi A, Iranshahi M, Abdollahi M. Antinociceptive effects of Peganum harmala L. alkaloid extract on mouse formalin test. J Pharm Pharm Sci. 2004;7:65–9. [PubMed] [Google Scholar]
24. Nasehi M, Piri M, Nouri M, Farzin D, Nayer-Nouri T, Zarrindast MR. Involvement of dopamine D1/D2 receptors on harmane-induced amnesia in the step-down passive avoidance test. Eur J Pharmacol. 2010;634:77–83. [PubMed] [Google Scholar]
25. Fortunato JJ, Réus GZ, Kirsch TR, Stringari RB, Stertz L, Kapczinski F, et al. Acute harmine administration induces antidepressive-like effects and increases BDNF levels in the rat hippocampus. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33:1425–30. [PubMed] [Google Scholar]
26. Farzin D, Mansouri N. Antidepressant-like effect of harmane and other beta-carbolines in the mouse forced swim test. Eur Neuropsychopharmacol. 2006;16:324–8. [PubMed] [Google Scholar]
27. Rommelspacher H, Schmidt LG, May T. Plasma norharman (beta-carboline) levels are elevated in chronic alcoholics. Alcohol Clin Exp Res. 1991;15:553–9. [PubMed] [Google Scholar]
28. Stohler R, Hug I, Knoll B, Mohler B, Ladewig D. Initial results with withdrawal treatments of male and female participants in the diversified Janus opiate prescription project in Basel. Praxis (Bern 1994) 1996;85:1537–41. [PubMed] [Google Scholar]
29. Pieroni A, Muenz H, Akbulut M, Başer KH, Durmuşkahya C. Traditional phytotherapy and trans-cultural pharmacy among Turkish migrants living in Cologne, Germany. J Ethnopharmacol. 2005;102:69–88. [PubMed] [Google Scholar]
30. Kuhn W, Müller T, Gerlach M, Sofic E, Fuchs G, Heye N, et al. Depression in Parkinson's disease: Biogenic amines in CSF of “de novo” patients. J Neural Transm. 1996;103:1441–5. [PubMed] [Google Scholar]
31. Splettstoesser F, Bonnet U, Wiemann M, Bingmann D, Büsselberg D. Modulation of voltage-gated channel currents by harmaline and harmane. Br J Pharmacol. 2005;144:52–8. [PMC free article] [PubMed] [Google Scholar]
32. Yu AM, Idle JR, Krausz KW, Küpfer A, Gonzalez FJ. Contribution of individual cytochrome P450 isozymes to the O-demethylation of the psychotropic beta-carboline alkaloids harmaline and harmine. J Pharmacol Exp Ther. 2003;305:315–22. [PubMed] [Google Scholar]
33. Herraiz T, Guillén H. Inhibition of the bioactivation of the neurotoxin MPTP by antioxidants, redox agents and monoamine oxidase inhibitors. Food Chem Toxicol. 2011;49:1773–81. [PubMed] [Google Scholar]
34. Yalcin D, Bayraktar O. Inhibition of catechol-O-methyltransferase (COMT) by some plant-derived alkaloids and phenolics. J Mol Catal. 2009;64:162–6. [Google Scholar]
35. Sokmen A, Jones BM, Erturk M. The in vitro antibacterial activity of Turkish medicinal plants. J Ethnopharmacol. 1999;67:79–86. [PubMed] [Google Scholar]
36. Storch A, Hwang YI, Gearhart DA, Beach JW, Neafsey EJ, Collins MA, et al. Dopamine transporter-mediated cytotoxicity of beta-carbolinium derivatives related to Parkinson's disease: Relationship to transporter-dependent uptake. J Neurochem. 2004;89:685–94. [PubMed] [Google Scholar]
37. Schwarz MJ, Houghton PJ, Rose S, Jenner P, Lees AD. Activities of extract and constituents of Banisteriopsis caapi relevant to parkinsonism. Pharmacol Biochem Behav. 2003;75:627–33. [PubMed] [Google Scholar]
38. Samoylenko V, Rahman MM, Tekwani BL, Tripathi LM, Wang YH, Khan SI, et al. Banisteriopsis caapi, a unique combination of MAO inhibitory and antioxidative constituents for the activities relevant to neurodegenerative disorders and Parkinson's disease. J Ethnopharmacol. 2010;127:357–67. [PMC free article] [PubMed] [Google Scholar]
39. Doetkotte R, Opitz K, Kiianmaa K, Winterhoff H. Reduction of voluntary ethanol consumption in alcohol-preferring Alko alcohol (AA) rats by desoxypeganine and galanthamine. Eur J Pharmacol. 2005;522:72–7. [PubMed] [Google Scholar]
40. Akhtar MS, Iqbal Z, Khan MN, Lateef M. Anthelmintic activity of medicinal plants with particular reference to their use in animals in the Indo±Pakistan subcontinent. Small Rumin Res. 2000;38:99–107. [Google Scholar]
41. Nenaah G. Antibacterial and antifungal activities of (beta)-carboline alkaloids of Peganum harmala (L) seeds and their combination effects. Fitoterapia. 2010;81:779–82. [PubMed] [Google Scholar]
42. Saadabi AM. Antifungal activity of some Saudi plants used in traditional medicine. Asian J Plant Sci. 2006;5:907–9. [Google Scholar]
43. Prashanth D, John S. Antibacterial activity of Peganum harmala. Fitoterapia. 1999;70:438–9. [Google Scholar]
44. Rharrabe K, Bakrim A, Ghailani N, Sayah F. Bioinsecticidal effect of harmaline on Plodia interpunctella development (Lepidoptera Pyralidae) Pestic Biochem Physiol. 2007;89:137–45. [Google Scholar]
45. Jbilou R, Amri H, Bouayad N, Ghailani N, Ennabili A, Sayah F. Insecticidal effects of extracts of seven plant species on larval development, alpha-amylase activity and offspring production of Tribolium castaneum (Herbst) (Insecta: Coleoptera: Tenebrionidae) Bioresour Technol. 2008;99:959–64. [PubMed] [Google Scholar]
46. Bremner P, Rivera D, Calzado MA, Obón C, Inocencio C, Beckwith C, et al. Assessing medicinal plants from South-Eastern Spain for potential anti-inflammatory effects targeting nuclear factor-Kappa B and other pro-inflammatory mediators. J Ethnopharmacol. 2009;124:295–305. [PubMed] [Google Scholar]
47. Di Giorgio C, Delmas F, Ollivier E, Elias R, Balansard G, Timon-David P. In vitro activity of the beta-carboline alkaloids harmane, harmine, and harmaline toward parasites of the species Leishmania infantum. Exp Parasitol. 2004;106:67–74. [PubMed] [Google Scholar]
48. Mirzaie M, Nosratabadi SJ, Derakhshanfar A, Sharifi I. Antileishmanial activity of Peganum harmala extract on the in vitro growth of Leishmania major promastigotes in comparison to a trivalent antimony drug. Veterinarski Arhiv. 2007;77:365–75. [Google Scholar]
49. Rahimi-Moghaddam P, Ebrahimi SA, Ourmazdi H, Selseleh M, Karjalian M, Haj-Hassani G, et al. In vitro and in vivo activities of Peganum harmala extract against Leishmania major. J Res Med Sci. 2011;16:1032–9. [PMC free article] [PubMed] [Google Scholar]
50. Khaliq T, Misra P, Gupta S, Reddy KP, Kant R, Maulik PR, et al. Peganine hydrochloride dihydrate an orally active antileishmanial agent. Bioorg Med Chem Lett. 2009;19:2585–6. [PubMed] [Google Scholar]
51. Mirzaiedehaghi M. Treatment of natural ovine malignant theileriosis with a chloroform extract of the plant Peganum harmala. Onderstepoort J Vet Res. 2006;73:153–5. [PubMed] [Google Scholar]
52. Mirzaei M. Treatment of natural tropical theileriosis with the extract of the plant Peganum harmala. Korean J Parasitol. 2007;45:267–71. [PMC free article] [PubMed] [Google Scholar]
53. Rivas P, Cassels BK, Morello A, Repetto Y. Effects of some beta-carboline alkaloids on intact Trypanosoma cruzi epimastigotes. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol. 1999;122:27–31. [PubMed] [Google Scholar]
54. Arshad N, Zitterl-Eglseer K, Hasnain S, Hess M. Effect of Peganum harmala or its beta-carboline alkaloids on certain antibiotic resistant strains of bacteria and protozoa from poultry. Phytother Res. 2008;22:1533–8. [PubMed] [Google Scholar]
55. Chen Q, Chao R, Chen H, Hou X, Yan H, Zhou S, et al. Antitumor and neurotoxic effects of novel harmine derivatives and structure-activity relationship analysis. Int J Cancer. 2005;114:675–82. [PubMed] [Google Scholar]
56. Li Y, Liang F, Jiang W, Yu F, Cao R, Ma Q, et al. DH334, a beta-carboline anti-cancer drug, inhibits the CDK activity of budding yeast. Cancer Biol Ther. 2007;6:1193–9. [PubMed] [Google Scholar]
57. Jahaniani F, Ebrahimi SA, Rahbar-Roshandel N, Mahmoudian M. Xanthomicrol is the main cytotoxic component of Dracocephalum kotschyii and a potential anti-cancer agent. Phytochemistry. 2005;66:1581–92. [PubMed] [Google Scholar]
58. Cao R, Peng W, Chen H, Ma Y, Liu X, Hou X, et al. DNA binding properties of 9-substituted harmine derivatives. Biochem Biophys Res Commun. 2005;338:1557–63. [PubMed] [Google Scholar]
59. Nafisi S, Malekabady ZM, Khalilzadeh MA. Interaction of β-carboline alkaloids with RNA. DNA Cell Biol. 2010;29:753–61. [PubMed] [Google Scholar]
60. Jiménez J, Riverón-Negrete L, Abdullaev F, Espinosa-Aguirre J, Rodríguez-Arnaiz R. Cytotoxicity of the beta-carboline alkaloids harmine and harmaline in human cell assays in vitro. Exp Toxicol Pathol. 2008;60:381–9. [PubMed] [Google Scholar]
61. Sobhani AM, Ebrahimi SA, Mahmoudian M. An in vitro evaluation of human DNA topoisomerase I inhibition by Peganum harmala L. seeds extract and its beta-carboline alkaloids. J Pharm Pharm Sci. 2002;5:19–23. [PubMed] [Google Scholar]
62. Hamden K, Silandre D, Delalande C, Elfeki A, Carreau S. Protective effects of estrogens and caloric restriction during aging on various rat testis parameters. Asian J Androl. 2008;10:837–45. [PubMed] [Google Scholar]
63. Hamden K, Carreau S, Ayadi F, Masmoudi H, El Feki A. Inhibitory effect of estrogens, phytoestrogens, and caloric restriction on oxidative stress and hepato-toxicity in aged rats. Biomed Environ Sci. 2009;22:381–7. [PubMed] [Google Scholar]
64. Hamden K, Masmoudi H, Ellouz F, ElFeki A, Carreau S. Protective effects of Peganum harmala extracts on thiourea-induced diseases in adult male rat. J Environ Biol. 2008;29:73–7. [PubMed] [Google Scholar]
65. Zaker F, Oody A, Arjmand A. A study on the antitumoral and differentiation effects of Peganum harmala derivatives in combination with ATRA on leukaemic cells. Arch Pharm Res. 2007;30:844–9. [PubMed] [Google Scholar]
66. Hamsa TP, Kuttan G. Harmine activates intrinsic and extrinsic pathways of apoptosis in B16F-10 melanoma. Chin Med. 2011;6:11. [PMC free article] [PubMed] [Google Scholar]
67. Mohammed S, Kasera KP, Shukla KJ. Unexploited plants of potential medicinal value from the Indian Thar desert. Nat Prod Radiance. 2004;3:69–74. [Google Scholar]
68. El Bahri L, Chemli R. Peganum harmala L: A poisonous plant of North Africa. Vet Hum Toxicol. 1991;33:276–7. [PubMed] [Google Scholar]
69. Bnouham M, Mekhfi H, Legssyer A, Ziyyat A. Medicinal plants used in the treatment of diabetes in Morocco. Int J Diabetes Metab. 2002;10:33–50. [Google Scholar]
70. Karaki H, Kishimoto T, Ozaki H, Sakata K, Umeno H, Urakawa N. Inhibition of calcium channels by harmaline and other harmala alkaloids in vascular and intestinal smooth muscles. Br J Pharmacol. 1986;89:367–75. [PMC free article] [PubMed] [Google Scholar]
71. Goel N, Singh N, Saini R. Efficient in vitro multiplication of syrian rue (Peganum harmala L.) using 6-benzylaminopurine pre-conditioned seedling explants. Nat Sci. 2009;7:129–34. [Google Scholar]
72. Merzouki A, Ed-derfoufi F, Molero Mesa J. Hemp (Cannabis sativa L.) and abortion. J Ethnopharmacol. 2000;73:501–3. [PubMed] [Google Scholar]
73. Yonezawa T, Hasegawa S, Asai M, Ninomiya T, Sasaki T, Cha BY, et al. Harmine, a β-carboline alkaloid, inhibits osteoclast differentiation and bone resorption in vitro and in vivo. Eur J Pharmacol. 2011;650:511–8. [PubMed] [Google Scholar]
74. Yonezawa T, Lee JW, Hibino A, Asai M, Hojo H, Cha BY, et al. Harmine promotes osteoblast differentiation through bone morphogenetic protein signaling. Biochem Biophys Res Commun. 2011;409:260–5. [PubMed] [Google Scholar]
75. Wang X, Wang H, He A. Study on the antitumor effect of total harmala. J China Med Univ. 1996;25:240–2. [Google Scholar]
76. Bellakhdar J. Medecine arabe ancienne et savoirs populaires. Paris: Ibis Press; 1997. La pharmacopee marocaine traditionnelle; pp. 529–30. [Google Scholar]
77. Nafisi S, Asghari MH, Nezhadi MA, Ekhtiari MS. Possible antidiabetic effect of Peganum harmala on streptozocine-induced mouse. World Appl Sci J. 2011;14:822–4. [Google Scholar]
78. Waki H, Park KW, Mitro N, Pei L, Damoiseaux R, Wilpitz DC, et al. The small molecule harmine is an antidiabetic cell-type-specific regulator of PPAR sssssgamma expression. Cell Metab. 2007;5:357–70. [PubMed] [Google Scholar]
79. Hamouda C, Amamou M, Thabet H, Yacoub M, Hedhili A, Bescharnia F, et al. Plant poisonings from herbal medication admitted to a Tunisian toxicologic intensive care unit, 1983-1998. Vet Hum Toxicol. 2000;42:137–41. [PubMed] [Google Scholar]
80. Ben Salah N, Amamou M, Jerbi Z, Ben Salah F, Yacoub M. Aspects cliniques, pharmacologiques et toxicologiques du surdosage par une plante medicinale: le harmel. Essaydali Scientifique. 1986;21:13–8. [Google Scholar]
81. Bellakhdar J, Claisse R, Fleurentin J, Younos C. Repertory of standard herbal drugs in the Moroccan pharmacopoea. J Ethnopharmacol. 1991;35:123–43. [PubMed] [Google Scholar]
82. Kahouaji MS. Contribution à une étude ethnobotanique des plantes médicinales au Maroc Oriental. Diplôme d’études supérieures de 3ème cycle. Université Mohamed Ier. 1995 Faculté des Sciences d’Oujda. Maroc. [Google Scholar]
83. Lamchouri F, Settaf A, Cherrah Y, El Hamidi M, Tligui N, Lyoussi B, et al. Experimental toxicity of Peganum harmala seeds. Ann Pharm Fr. 2002;60:123–9. [PubMed] [Google Scholar]
84. Zayed R. Efficient in vitro elicitation of b-carboline alkaloids in transformed root cultures of Peganum harmala. Bull Fac Pharm. 2011;49:7–11. [Google Scholar]
85. Eddouks M, Maghrani M, Lemhadri A, Ouahidi ML, Jouad H. Ethnopharmacological survey of medicinal plants used for the treatment of diabetes mellitus, hypertension and cardiac diseases in the south-east region of Morocco (Tafilalet) J Ethnopharmacol. 2002;82:97–103. [PubMed] [Google Scholar]
86. James AD. Boca Raton Fla: CRC Press; c2001. Handbook of Phytochemical Constituents of GRAS Herbs and Other Economic Plants; p. 654. [Google Scholar]
87. Al-Quran S. Taxonomical and pharmacological survey of therapeutic plants in Jordan. J Nat Prod. 2008;1:10–26. [Google Scholar]
88. Abdel Aziz NG, Abdel Kader SM, El-Sayed MM, EL-Malt EA, Shaker ES., editors. Novel carboline alkaloidfrom Peganum harmala as antibacterial agant. Proceedings of the Tenth Radiation Physics and Protection Conference. 2010 Nov;:27–30. Egypt 359. [Google Scholar]
89. Mohagheghzadeh A, Faridi P, Shams-Ardakani M, Ghasemi Y. Medicinal smokes. J Ethnopharmacol. 2006;108:161–84. [PubMed] [Google Scholar]
90. Brobst A, Lewis J, Klett B, Haustein C, Shriver J. The free base extraction of harmaline from Peganum harmala. Am J Undergrad Res. 2009;8:2–3. [Google Scholar]
91. Lamchouri F, Settaf A, Cherrah Y, Zemzami M, Lyoussi B, Zaid A, et al. Antitumour principles from Peganum harmala seeds. Therapie. 1999;54:753–8. [PubMed] [Google Scholar]
92. Nafisi S, Bonsaii M, Maali P, Khalilzadeh MA, Manouchehri F. Beta-carboline alkaloids bind DNA. J Photochem Photobiol B. 2010;100:84–91. [PubMed] [Google Scholar]
93. El Gendy MA, Soshilov AA, Denison MS, El-Kadi AO. Harmaline and harmalol inhibit the carcinogen-activating enzyme CYP1A1 via transcriptional and posttranslational mechanisms. Food Chem Toxicol. 2012;50:353–62. [PMC free article] [PubMed] [Google Scholar]
[[Category:Treatments]]
[[Category:Herbal medicine]]